Kolexia
Drieu La Rochelle Laurianne
Hématologie
Centre hospitalier de Tours
Tours, France
33 Activités
3 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Syndrome de libération de cytokines Lymphome T Lymphome T périphérique Leucémie-lymphome lymphoblastique à précurseurs B et T Hypercalcémie Leucémie myélomonocytaire chronique

Industries

Gilead
5 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2023
Amgen
3 collaboration(s)
Dernière en 2022
Sanofi
2 collaboration(s)
Dernière en 2021

Dernières activités

MorningLyte: A Phase III Randomized, Open-label, International, Multicenter Study Evaluating the Efficacy and Safety of Mosunetuzumab Plus Lenalidomide in Comparison to Anti-CD20 Monoclonal Antibody Plus Chemotherapy in Subjects With Previously Untreated FLIPI 2-5 Follicular Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome. A DESCAR-T study.
Blood advances   04 janvier 2024
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
TRANSCRIPT: Transplantation After Complete Response In Patients With T-cell Lymphoma
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
Essai Clinique (Novartis)   25 septembre 2023
Cerebral localization of chronic myelomonocytic leukemia and improvement with high-dose cytarabine: A case report.
EJHaem   23 juin 2023
Transfusion needs after CD19 CAR T-cells for large B-cell lymphoma: Predictive factors and impact on outcome
Abstracts of the 33rd Regional Congress of the ISBT Gothenburg, Sweden 17–21 June 2023   12 juin 2023
Transfusion needs after CD19 CAR T-cells for large B-cell lymphoma: predictive factors and impact on outcome. A DESCAR-T study.
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma: A Randomized Phase II Trial Evaluating Ibrutinib Plus CD20 Ab and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   16 mars 2023